arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

electroCore, Inc.

ECOR
$8.22 ▲ +1.65 (+25.11%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
10 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
30
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

electroCore, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap
Dividend Yield
Revenue Growth 27.2%
Op. Margin -41.1%
ROIC -217.3%
FCF / Share
Trailing P/E
Price / Book
FCF Yield
Debt / Equity -4.54
info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$32.03M
↑ +27.2%
Net Income Profit after all expenses
$-13.97M
↓ -17.5%
Operating Margin Operating profit as % of sales
-41.1%
↑ +15.0% 6th
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
7
Financial Health
52
Cash Quality
44

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 38 quarters